Cargando…
Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK
BACKGROUND: Chemoresistance is a significant clinical problem in pancreatic cancer (PC) and underlying molecular mechanisms still remain to be completely understood. Here we report a novel exosome-mediated mechanism of drug-induced acquired chemoresistance in PC cells. METHODS: Differential ultracen...
Autores principales: | Patel, Girijesh Kumar, Khan, Mohammad Aslam, Bhardwaj, Arun, Srivastava, Sanjeev K, Zubair, Haseeb, Patton, Mary C, Singh, Seema, Khushman, Moh'd, Singh, Ajay P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5344296/ https://www.ncbi.nlm.nih.gov/pubmed/28152544 http://dx.doi.org/10.1038/bjc.2017.18 |
Ejemplares similares
-
Comparative analysis of exosome isolation methods using culture supernatant for optimum yield, purity and downstream applications
por: Patel, Girijesh Kumar, et al.
Publicado: (2019) -
Molecular Drivers of Pancreatic Cancer Pathogenesis: Looking Inward to Move Forward
por: Khan, Mohammad Aslam, et al.
Publicado: (2017) -
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
por: Nakano, Y, et al.
Publicado: (2007) -
Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer
por: Azim, Shafquat, et al.
Publicado: (2016) -
Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)